Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial

S Chopra, S Gupta, S Kannan, T Dora… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Postoperative Adjuvant Radiation in Cervical Cancer (PARCER), a phase III
randomized trial, compared late toxicity after image-guided intensity-modulated radiotherapy …

Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG Oncology–RTOG 1203

AH Klopp, AR Yeung, S Deshmukh, KM Gil… - Journal of clinical …, 2018 - ascopubs.org
Purpose NRG Oncology/RTOG 1203 was designed to compare patient-reported acute
toxicity and health-related quality of life during treatment with standard pelvic radiation or …

Current standards in the management of early and locally advanced cervical cancer: update on the benefit of neoadjuvant/adjuvant strategies

Y Zhou, E Rassy, A Coutte, S Achkar, S Espenel… - Cancers, 2022 - mdpi.com
Simple Summary Cervical cancers is a human papillomavirus infection-induced gynecologic
cancer. Due to the uneven access to prevention measures in the world, it is still a leading …

NRG oncology/RTOG consensus guidelines for delineation of clinical target volume for intensity modulated pelvic radiation therapy in postoperative treatment of …

W Small Jr, WR Bosch, MM Harkenrider… - International Journal of …, 2021 - Elsevier
Purpose Accurate target definition is critical for the appropriate application of radiation
therapy. In 2008, the Radiation Therapy Oncology Group (RTOG) published an international …

The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I–II cervical cancer: A review

M Takekuma, Y Kasamatsu, N Kado… - Journal of Obstetrics …, 2017 - Wiley Online Library
The treatment for most patients with early‐stage cervical cancer involves radical
hysterectomy and pelvic lymph node dissection, and indications for postoperative adjuvant …

Radiation therapy for endometrial cancer: an American society for radiation oncology clinical practice guideline

MM Harkenrider, N Abu-Rustum, K Albuquerque… - Practical radiation …, 2023 - Elsevier
Purpose With the results of several recently published clinical trials, this guideline informs on
the use of adjuvant radiation therapy (RT) and systemic therapy in the treatment of …

Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-IVA cervical cancer: an international multicenter phase II clinical trial …

LK Mell, I Sirák, L Wei, R Tarnawski… - International Journal of …, 2017 - Elsevier
Purpose To test the hypothesis that intensity modulated radiation therapy (IMRT) reduces
acute hematologic and gastrointestinal (GI) toxicity for patients with locoregionally advanced …

External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized …

BG Sorbe, G Horvath, H Andersson, K Boman… - International Journal of …, 2012 - ijgc.bmj.com
Background A combination of vaginal brachytherapy and external beam radiotherapy was
compared with brachytherapy alone in medium-risk endometrial carcinomas. Quality-of-life …

[HTML][HTML] Cancer of the cervix uteri

A Bermudez, N Bhatla, E Leung - International Journal of Gynecology & …, 2015 - Elsevier
Worldwide, cervical cancer is now the fourth most common female malignancy in both
incidence and mortality, following breast, colorectal, and lung cancers, and results in …

COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation

VM Williams, JM Kahn, MM Harkenrider, J Chino… - Brachytherapy, 2020 - Elsevier
Purpose The purpose of this study was to highlight the importance of timely brachytherapy
treatment for patients with gynecologic, breast, and prostate malignancies, and provide a …